Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial

Z. Punthakee, N. Almeras, J.-P. Despres, G. R. Dagenais, S. S. Anand, D. L. Hunt, A. M. Sharma, H. Jung, S. Yusuf and H. C. Gerstein

Diabetic Medicine 31 ( 9 ): 1086 - 1092 , 2014